Hepatitis Monthly

Published by: Neoscriber Demo Publisher
Crossmark

Effect and Predictive Elements for 52 Weeks’ Telbivudine Treatment on Naïve HBeAg positive Chronic Hepatitis B

Xiao-Feng Zhu 1 , Li-Xia Lu 2 , Ying Wang 3 , Kong-wen Xu 3 , Da-jiang Li 4 , Xia Zhu 5 , Li Liu 5 , Cong Liu 5 , Jin-Rong Wang 5 , Hong Tang 5 and Lichun Wang 4 , *
Authors Information
1 Δepidemiology Department, West China School of public Health, Sichuan University, Chengdu, China
2 epidemiology Department, West China School of public Health, Sichuan University , Chengdu, China
3 epidemiology Department, West China School of public Health, Sichuan University , Chengdu, China.
4 Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, China
5 Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, China.
Article information
  • Hepatitis Monthly: December 31, 2011, 11 (12); e93029
  • Published Online: December 31, 2011
  • Article Type: Research Article
  • Received: May 06, 2019
  • Accepted: December 31, 2011
  • DOI: 10.5812/kowsar.1735143X.795

To Cite: Zhu X, Lu L, Wang Y, Xu K, Li D, et al. Effect and Predictive Elements for 52 Weeks’ Telbivudine Treatment on Naïve HBeAg positive Chronic Hepatitis B, Hepat Mon. 2011 ; 11(12):e93029. doi: 10.5812/kowsar.1735143X.795.

Abstract
© 2011, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Fulltext
References
  • 1. The references are available in the PDF file.
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments